Andrew McNeill
Director of Research - Equity at Cumulus Oncology Ltd.
Profile
Andrew McNeill is an Investor Director at Cumulus Oncology Ltd., an Investor Director at Dxcover Ltd., and a Partner at EOS Syndicate Management Ltd.
He was previously the Chairman at Chromacity Ltd.
from 2017 to 2019.
He received his undergraduate degree from the University of Leeds in 2003.
Andrew McNeill active positions
| Companies | Position | Start |
|---|---|---|
EOS Syndicate Management Ltd.
 EOS Syndicate Management Ltd. Investment ManagersFinance EOS Syndicate Management is an independent venture capital firm founded in 2014 by Kevin Grainger. The firm is headquartered in Scotland, United Kingdom. | Private Equity Investor | - |
Cumulus Oncology Ltd.
 Cumulus Oncology Ltd. Pharmaceuticals: MajorHealth Technology Cumulus Oncology Ltd. develops oncology drugs. The company was founded by Clare Wareing on November 13, 2017 and is headquartered in Edinburgh, the United Kingdom. | Director of Research - Equity | - |
Dxcover Ltd.
 Dxcover Ltd. Medical SpecialtiesHealth Technology Clinspec Diagnostics Ltd. provides serum diagnostic for cancer. It enables blood analysis using artificial intelligence for early detection of cancers and other diseases. The company was founded by Mark Hegarty and David S. Palmer and is headquartered in Glasgow, the United Kingdom. | Private Equity Investor | 2019-02-28 |
Former positions of Andrew McNeill
| Companies | Position | End |
|---|---|---|
Chromacity Ltd.
 Chromacity Ltd. Medical SpecialtiesHealth Technology Chromacity Ltd. designs, manufactures and supplies ultrafast fibre lasers. Its products include spark 1040, OPO, FIR and custom systems. The firm’s applications include life sciences, security and defence, environmental sensing and fundamental research. The company was founded by Christopher Leburn, Derryck Reid and Carl Farrell in 2013 and is headquartered in Riccarton, the United Kingdom. | Chairman | 2019-10-31 |
Training of Andrew McNeill
| University of Leeds | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
EOS Syndicate Management Ltd.
EOS Syndicate Management Ltd. Investment ManagersFinance EOS Syndicate Management is an independent venture capital firm founded in 2014 by Kevin Grainger. The firm is headquartered in Scotland, United Kingdom. | Finance |
Chromacity Ltd.
Chromacity Ltd. Medical SpecialtiesHealth Technology Chromacity Ltd. designs, manufactures and supplies ultrafast fibre lasers. Its products include spark 1040, OPO, FIR and custom systems. The firm’s applications include life sciences, security and defence, environmental sensing and fundamental research. The company was founded by Christopher Leburn, Derryck Reid and Carl Farrell in 2013 and is headquartered in Riccarton, the United Kingdom. | Health Technology |
Cumulus Oncology Ltd.
Cumulus Oncology Ltd. Pharmaceuticals: MajorHealth Technology Cumulus Oncology Ltd. develops oncology drugs. The company was founded by Clare Wareing on November 13, 2017 and is headquartered in Edinburgh, the United Kingdom. | Health Technology |
Dxcover Ltd.
Dxcover Ltd. Medical SpecialtiesHealth Technology Clinspec Diagnostics Ltd. provides serum diagnostic for cancer. It enables blood analysis using artificial intelligence for early detection of cancers and other diseases. The company was founded by Mark Hegarty and David S. Palmer and is headquartered in Glasgow, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Andrew McNeill
